FDA Inspection
Merck Serono SAMerck Serono SA – FDA Inspection, May 9, 2018
Record Details
This FDA Inspection record concerns Merck Serono SA, with an inspection on May 9, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9b6ada5e-805a-412e-b05b-6de574a13d76
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1051545
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.198(a)Complaints reviewed by Quality Control Unit
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Merck Serono SA
8| Date | Classification | Office | Project area |
|---|---|---|---|
| November 25, 2025 | Not classified | Office of Inspections and Investigations | |
| May 2, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck Serono SA
- FDA Inspection 1298388 - 2025-11-25
- FDA Inspection 1209187 - 2023-05-02
- FDA Inspection 1122463 - 2020-02-18
- FDA Inspection 947757 - 2015-11-06
- FDA Inspection 857686 - 2013-11-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.